RECOGNITION AND ASSESSMENT

  • Consider liver failure in all patients with
    • abnormal liver function tests or coagulopathy
    • whose conscious level deteriorates

Symptoms and signs

  • Jaundice
  • Evidence of coagulopathy (e.g. bruising, petechiae)
  • Flap
  • Ascites and oedema
  • Malaise, nausea, vomiting
  • Altered conscious level (hepatic encephalopathy)

Investigations

  • FBC, INR
  • U&E
    • monitor regularly for onset of AKI
  • Bone profile and magnesium
  • Blood glucose
  • LFT
  • ABG

Acute hepatitis e.g. ALT >400

  • Hepatitis E IgM, Hepatitis A IgM, HBsAg and HBc IgM
    • if virology negative, EBV and CMV
  • Even if there is no evidence of paracetamol overdose, check paracetamol level
  • Liver antibodies
    • SMA, ANA, AMA, LKM (liver-kidney-microsome) and ANCA

Acute on chronic liver failure

  • HCVAb, HBV markers
  • Liver antibodies
    • SMA, ANA, AMA, LKM (liver-kidney-microsome) and ANCA
  • Blood cultures (mandatory)
    • including in decompensated alcohol related liver
  • Ascitic fluid culture and white cell count (mandatory)
  • Urine cultures
  • ABG (on air)
  • CXR

SEVERITY

Grade of encephalopathy

Look for evidence of multiple organ failure

  • Patient looks severely ill/exhausted/obtunded
  • Hypotension (mean arterial pressure <80 mmHg)
    • despite initial fluid administration +/- inotrope dependency
  • Oliguria/anuria
  • Spontaneous bruising and/or mucosal bleeding
  • Cerebral oedema
    • evidence: bradycardia, hypertension, dilated pupils or decerebrate posturing
  • Impaired gas transfer
    • hypoxaemia (PaO2 <10 kPa) despite 40% oxygen
  • Metabolic acidosis
  • Hypoglycaemia
  • Radiological pulmonary shadowing/oedema

Look for decompensated cirrhosis

Definition

  • Patients with known or suspected cirrhosis with an acute deterioration in liver function with:
    • jaundice
    • increasing ascites
    • hepatic encephalopathy
    • renal impairment
    • GI bleeding

Action

  • Decompensated cirrhosis is a medical emergency
  • Commence Decompensated Cirrhosis Care Bundle within first 6 hr of admission

MANAGEMENT

Admission

  • Admit to Liver ward or critical care
  • Inform a senior member of on-call medical team (SpR or above)
  • After patient review, contact on-call gastroenterologist for urgent assistance
    • where appropriate discuss with regional liver unit

Indications for consideration of transfer to critical care

  • Other organ failure in patients with acute liver failure
    • e.g. respiratory failure and cardiovascular instability
  • Grade 3 or 4 encephalopathy
  • Features of cerebral oedema

Fluid management

Hypoglycaemia or hyperglycaemia

  • Use regimen recommended in Control of hyperglycaemia unable to eat and drink guideline

Glucose normal

  • Correct intravascular fluid depletion with albumin 4.5%
  • Give maintenance crystalloid 3 L/day to maintain serum Na+ >130 mmol/L
    • give pre-mixed bags of sodium chloride 0.9% with 20 or 40 mmol/L potassium chloride to maintain serum K+ >3.5 mmol/L

Hypophosphataemia

  • Correct with phosphate polyfusor (Fresenius Kabi) IV
    • 500 mL bag gives 81 mmol sodium, 9.5 mmol potassium and 50 mmol phosphate
    • moderate hypophosphataemia (0.5–0.7 mmol/L), treat with 0.1–0.2 mmol phosphate/kg (equivalent to 1–2 mL/kg) over 12 hr
    • severe hypophosphataemia (<0.5 mmol/L), treat with 0.2–0.5 mmol phosphate/kg (equivalent to 2–5 mL/kg) over 12 hr
    • total maximum dose of 50 mmol per infusion
    • repeat doses may be required on subsequent days
    • reduce dosage in elderly patients and those with reduced renal function

Respiratory failure

  • Correct hypoxia – see Oxygen therapy in acutely hypoxaemic patients guideline

Coagulopathy

  • If INR >1.4 with significant bleeding or need to perform an invasive procedure, give phytomenadione (Konakion MM) 10 mg IV daily by slow IV infusion in 55 mL glucose 5%
  • If bleeding, discuss with on-call haematologist
  • Do not give fresh frozen plasma unless clinical evidence of bleeding

Infection

  • Treat all infections as serious as these patients exhibit few clinical signs of infection

Penicillin Allergy

  • True penicillin allergy is rare
  • Ask the patient and record what happened when they were given penicillin
  • If any doubt about whether patient is truly allergic to penicillin, seek advice from a microbiologist or consultant in infectious diseases
Only accept penicillin allergy as genuine hypersensitivity if convincing history of either rash within 72 hr of dose or anaphylactic reaction

Infection Control alerts

  • Check for IC alert
    • if IC alert not available, check previous 12 months of microbiology reports
  • If MRSA present, treat as tagged for MRSA. See MRSA management
  • If ESBL, MGNB, CARB present, treat as tagged for ESBL. See ESBL/MGNB/CARG management

Choice of anti-microbials

Select one

  • Discuss with microbiologist for empirical treatment
  • Amoxicillin 2 g IV 8-hrly
    • oral step down: co-amoxiclav 625 mg oral 8-hrly (check sensitivity results)
  • Fluconazole 200 mg IV by infusion daily for 2 days
    • then fluconazole 200 mg oral daily for 5 days
  • Ceftriaxone 1 g IV daily
    • oral step down: ciprofloxacin 500 mg orally 12-hrly (check sensitivity results)
  • Fluconazole 200 mg IV by infusion daily for 2 days
    • then fluconazole 200 mg oral daily for 5 days
  • Ciprofloxacin 400 mg IV 12-hrly
    • oral step down: ciprofloxacin 500 mg orally 12-hrly (check sensitivity results)
  • Fluconazole 200 mg IV by infusion daily for 2 days
    • then fluconazole 200 mg oral daily for 5 days

Duration of anti-microbial treatment

  • If not responding after 48 hr or further deterioration in liver or renal function, discuss with consultant microbiologist/ID
  • When significantly improved and >48 hr apyrexial, consider stopping

Encephalopathy

  • Consider giving Pabrinex IV-see Alcohol withdrawal guideline
  • Assess for precipitant
  • If clinical doubt in a confused patient, request CT head to exclude subdural haematoma
  • Except in fulminant liver failure, give lactulose 30–50 mL oral or via nasogastric (NG) tube 8-hrly, or phosphate enema rectally daily
    • adjust dosage to produce 2–3 soft stools daily. It is not necessary to produce diarrhoea
  • Avoid sedatives (benzodiazepines, phenothiazines, opioids)

COMPLICATIONS

Varices

  • If evidence of upper Gl haemorrhage, refer to gastroenterology team for advice on:
    • terlipressin infusion (must be used with caution in acute liver failure) and
    • possible endoscopy and variceal banding. See Acute upper gastrointestinal haemorrhage guideline

Ascites

  • Do not treat urgently unless it is causing symptoms
    • if encephalopathic, avoid or stop diuretics even if symptomatic
  • If ascites symptomatic, give spironolactone 100 mg oral daily
    • increasing by 100 mg every 2–3 days if necessary (max 400 mg daily)
    • to achieve weight reduction of 0.5–1 kg/day
  • If spironolactone not effective, furosemide 40 mg oral daily (max 40 mg 12-hrly) may be added
  • If hyponatraemia Na <120 mmol/L or creatinine increases x 2 or above 200 micromol/L, discontinue both diuretics

 Ascitic drainage

  • If drainage thought necessary, stop diuretics for 48 hr around period of paracentesis
    • replace fluid volume drained with IV infusions of albumin (albumin 20% 100 mL IV over 1 hr at outset)
    • repeated for every 3 L of fluid drained

Spontaneous bacterial peritonitis (non CAPD)

  • If condition deteriorates or there is evidence of sepsis, exclude SBP
    • carries a high mortality
    • arrange urgent ascitic tap for MC&S and ascitic fluid WCC
  • If SBP confirmed (ascitic PMN >250 x 106/L)
    • give albumin 1.5 g/kg IV over 24 hr and 1 g/kg on day 3 over 24 hr
    • start antimicrobials and antifungals

Choice of anti-microbials

Select one

  • Discuss with consultant microbiologist/ID consultant for empirical treatment
  • Piperacillin-tazobactam 4.5 g IV 8-hrly
    • oral step down: according to sensitivity results when available
  • Fluconazole 200 mg IV by infusion daily for 2 days
    • then fluconazole 200 mg oral daily for 5 days
  • Ceftriaxone 1 g IV daily
    • oral step down: Ciprofloxacin 500 mg orally 12-hrly (check sensitivity results)
  • Fluconazole 200 mg IV by infusion daily for 2 days
    • then fluconazole 200 mg oral daily for 5 days
  • Ciprofloxacin 400 mg IV 12-hrly
    • oral step down: ciprofloxacin 500 mg orally 12-hrly (check sensitivity results)
  • Fluconazole 200 mg IV by infusion daily for 2 days
    • then fluconazole 200 mg oral daily for 5 days

Duration of anti-microbial treatment

  • If not responding after 48 hr or further deterioration in liver or renal function, discuss with consultant microbiologist/ID
  • With clinical improvement, switch to oral antimicrobials (total duration 5–10 days)
  • When significantly improved and >48 hr apyrexial, consider stopping
  • At end of course, in cirrhotic patients only after first confirmed episode of SBP, start prophylactic ciprofloxacin 500 mg oral once daily on discharge
    • continue until ascites resolved

AKI and/or hyponatraemia (Na <125 mmol/L)

  • If patient develops hyponatraemia (<125 mmol/L) or doubling of serum creatinine, stop diuretics
    • only if no renal impairment, restrict fluid and salt intake

AKI defined by Rifle criteria

  • Increase in serum creatinine ≥26μmol/L within 48 hr or
  • ≥50% rise in serum creatinine over the last 7 days or
  • Urine output (UO) <0.5 mL/kg/hr for more than 6 hr based on dry weight or
  • Clinically dehydrated

Treatment

  • Suspend all diuretics and nephrotoxic drugs
  • Fluid resuscitate with human albumin solution 5% or sodium chloride 0.9%
    • 250 mL boluses with regular reassessment: 1–2 L will correct most losses
  • Initiate fluid balance chart/daily weights
  • Aim for MAP >80 mmHg to achieve UO >0.5 mL/kg/hr based on dry weight
  • At 6 hr, if target not achieved or NEWS worsening, consider escalation to higher level of care

Cerebral oedema

  • Refer to critical care and with their support
  • Disturb as little as possible and nurse at 45 degrees head up
  • Treat seizures. See Status epilepticus guideline
  • Avoid terlipressin
  • Aim to maintain serum Na+ >140 mmol/L with sodium chloride 1.8% by IV infusion
  • For acute episodes, give mannitol 20% (200 g in 1 L) 0.25–2 g/kg by IV infusion (use 15–30 micron in-line filter) through large peripheral or central vein over 30–60 min
    • if urine output and/or serum osmolality fail to rise or vital signs deteriorate, repeat 1–2 times after 4–8 hr

MONITORING TREATMENT

In-day

  • Pulse oximetry continuously
  • Urine output hourly
  • Blood glucose 2-hrly
  • BP 4-hrly
  • Pulse 4-hrly
  • Temperature 4-hrly
  • Conscious level 4-hrly

Daily

  • If following paracetamol overdose, twice daily
  • FBC, INR
  • U&E
  • Weight and fluid balance

Alternate days

  • LFT, bone profile and magnesium

DISCHARGE AND FOLLOW UP

  • Discharge when recovered
  • Discuss need for follow-up with gastroenterology team

© 2022 The Bedside Clinical Guidelines Partnership.

Created by University Hospital North Midlands and Keele University School of Computing and Mathematics.

Research and development team: James Mitchell, Ed de Quincey, Charles Pantin, Naveed Mustfa